• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/8

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

8 Cards in this Set

  • Front
  • Back
COX-1
constitutive enzyme that is expressed in most tissues

makes prostanoids for "housekeeping"

notables:
PGE2, PGFα2 = gastric mucosal protection
TXA2= platelet aggregation, vasoconstriction
PGI2= inhibitor of platelet aggregation and vasodilation
COX-2
Inducible- upregulated by stress, growth factors and cytokines
-constitutive in kidneys and brain


source of prostanoids in inflammation and cancer

notables:
prostacyclin= dev. and function of kidneys
PGE2= pain, patent ductus arteriosus
PGI2= inhibits gastric acid secretion, keeps TXA2 in balance
NSAID actions
anti-inflammation
anti-pyrexia
analgesia
increases alveolar ventilation(salicylates)
decrease renal blood blow
inhibit platelet aggregation, increase bleeding time
NSAID uses
1.prophylaxis for cardiovascular events
2.antipyretic, analgesia
3.antiinflammatory
4. reduces risk of colon cancer
NSAID doses
analgesia:
two 325mg tablets 4x per day

antiinflammatory:
45mg/kg/d in divided doses

salicylates= analgesic in low doses, anti-inflammatory in high doses
NSAID Adverse Effects
GI- gastritis
Blood- prolonged bleeding time
Resp- resp acidosis and metabolic acidosis
-in acute= resp alkalosis, metabolic acidosis
Liver- may elevate enzymes, hepatitis

Hypersensitivity rxns
Reye's syndrome in children- use acetaminophen instead.

dose of less than 2g= inc. in uric a.
dose of more than 4g= dec in urate levels.
-salicylate compete with uric a.
Celecoxib, etoricoxib, meloxicam
COX-2 selective inhibitors

less GI adverse effects
no cardiocascular effects since TXA2 from COX-1

-associated with prothrombotic state because TXA2, PGI2 balance altered since COX-2 inhibition= no PGI2

only celecoxib in USA
etoricoxib most selectivity
meloxicam least selectivity

U: inflammatory disorders

AD: GI, renal, celecoxib= hypersensitivity rxns
Acetaminophen
NOT an NSAID
-weak inhibition of COX-1/2

no anti-inflammatory effects; only analgesia and anti-pyrexia
-via unknown mechanism (COX-3?)

AD: large doses= hepatotoxin
-antidote=acetylcysteine